Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Nanobiotix Appoints Dr. Alain Herrera to the Supervisory Board

Published: Thursday, February 14, 2013
Last Updated: Thursday, February 14, 2013
Bookmark and Share
Former Global Oncology Head from Sanofi-Aventis joins the Nanobiotix team.

Nanobiotix has announced that Dr. Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun in their roles, as part of a planned Supervisory Board succession.

Dr. Herrera joins Nanobiotix Supervisory Board with more than 25 years of experience in the pharmaceutical industry with a strong focus in oncology drug development and marketing.

Before setting up his own oncology consultancy - Alain Oncologie Consulting (AOC) -, he headed the Oncology business at Sanofi-Aventis for ten years, where he was Vice President for the Global Oncology Business Strategy and Development (2007-2008) and Head of the Global Oncology Franchise (1998-2007).

He contributed to the worldwide registration of Oxaliplatin (Eloxatin®) and Rasburicase (Fasturtec®/Elitek®), as well as the Gastric and Head & Neck indications for Docetaxel (Taxotere®).

His previous responsibilities within the pharmaceutical industry included the roles of Chairman of Chiron Therapeutics Europe, Managing Director at Pierre Fabre Oncology Laboratories and Head of the Oncology Platform at Roger Bellon (Rhône Poulenc).

In addition to these roles, since 1991, Dr. Herrera has been a Hematologist Consultant at Antoine Beclere Hospital.

Dr. Herrera said: “Over recent years, Nanobiotix’s nanomedicine technology has repeatedly demonstrated its significant potential for optimizing the efficacy of radiotherapy, a treatment currently used for about 60% of cancer patients and a key component of the treatment strategy in curative setting. I'm both delighted and privileged to be able to play a part in helping Nanobiotix to deliver its objectives and to overcome the challenges that lie ahead. I look forward to working with the Nanobiotix team.”

“We welcome Dr. Alain Herrera to the Supervisory Board. Pioneer of industrial oncology, his business and pharmaceutical industry experience will add important expertise to the Board,” said Laurent Levy, CEO of Nanobiotix.

Levy continued, “Alain has been a member of the Scientific Advisory Board of Nanobiotix over the past years, so he already has a thorough knowledge of its business and its technology. We believe his skills and oncology leadership will assist us in fulfilling our strategic business objectives and to progress our international development.”

Laurent Levy added: "I would also like to thank Thierry Chopin and Isabelle Bou Antoun for the contribution they have made over the last years of service, helping to position Nanobiotix for a promising future."

The nomination of Dr. Herrera will be submitted to the approval of the next general shareholders’ meeting in accordance with applicable law.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nanobiotix Half Year Results for the Six Months Ended 30 June 2014
Significant operational and clinical progress made.
Tuesday, September 02, 2014
Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply
Mr Otin will be responsible for the manufacturing plans to move NBTXR3 from clinical trials.
Thursday, April 17, 2014
Nanobiotix Sees Clinical Advance in STS Pilot Trial with Lead Product, NBTXR3
Market development plan outlined for earlier potential launch in 2016.
Tuesday, February 11, 2014
Nanobiotix Strengthens its Supervisory Board for the Next Stage of its Development
Anne-Marie GRAFFIN and Enno SPILLNER join the Supervisory Board.
Thursday, January 30, 2014
Nanobiotix Strengthens its Supervisory Board for the Next Stage of its Development
Anne-Marie GRAFFIN and Enno SPILLNER join the Supervisory Board.
Thursday, January 30, 2014
Nanobiotix 2013 Review: Significant Corporate and Clinical Progress
Company announces its prospective financial communications calendar for the fiscal year 2014.
Friday, January 10, 2014
NANOBIOTIX honored at the INVESTOR AWARDS 2013 in the “Young Talent” category
NANOBIOTIX announced it has been awarded the “Young Talent” Award at the INVESTOR AWARDS 2013, referring to a newly listed company.
Friday, November 08, 2013
Nanobiotix Announces €2.8 Million Grant to Develop NBTXR3
Through ETPN, Nanobiotix is driving nanomedicine in Europe and is now involved in the first nanomedicine consortium in France with the launch of NICE project.
Friday, July 05, 2013
Nanobiotix Receives Approval from ANSM to Start New Clinical Trial with NBTXR3
Second indication for NanoXray product in Head and Neck cancer patients.
Thursday, June 13, 2013
NANOBIOTIX Announced Positive Phase I Results of NBTXR3
Company’s NBTXR3 achieves clinical milestone reaching proof-of-concept in phase I trial of STS.
Tuesday, June 04, 2013
Dr. Laurent Levy, CEO of Nanobiotix, Receives UB Entrepreneurship Award
Nanobiotix announces that its CEO and co-founder, Dr. Laurent Levy, has received the award at the Annual Inventors and Entrepreneurs Reception at the University at Buffalo (UB).
Thursday, April 04, 2013
Nanobiotix Selected to Present at Future Leaders in the Biotech Industry Conference
Laurent Levy to give a Company Presentation at the 20th Annual Future Leaders in New York.
Wednesday, March 20, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos